Updates from The Motley Fool

Latest updates on Smith & Nephew from Fool.com.

Stock Performance

SNN vs. S&P 500 | 2 Year Performance
SNN 1-Day Stock Chart
SNN 5-Day Stock Chart
SNN 1-Month Stock Chart
SNN 3-Month Stock Chart
SNN 6-Month Stock Chart
SNN 1-Year Stock Chart
SNN 2-Year Stock Chart
SNN 5-Year Stock Chart
View Interactive SNN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Smith & Nephew.
Current Price: $34.78
Prev Close: $34.72
Open: $34.70
Bid: $31.62
Ask: $0.00
Day's Range: $34.70 - $34.89
52wk Range: $30.23 - $37.84
Volume: 189,427
Avg Vol 413,554
Market Cap: $16.54B
P/E (ttm): 28.23
EPS (ttm): $0.00
Div & Yield: $0.47 (1.7%)

Company Rating

What our community thinks about Smith & Nephew.
CAPS Rating 4 out of 5
119 Outperform
11 Underperform
CAPS All Stars
32 Outperform
4 Underperform

How do you think Smith & Nephew will perform against the market?

You pick for Smith & Nephew is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Olivier Bohuon, CEO

49% Approve

Based on 83 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Smith & Nephew.

The Company is a global business engaged in the development, manufacture and marketing of medical devices in the sectors of orthopaedic reconstruction, orthopaedic trauma and clinical therapies, endoscopy and advanced wound management.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Healthcare IT